Gratus Capital LLC Pfizer Inc Transaction History

Gratus Capital LLC

$2.39 Billion
Q2 2024

A detailed history of Gratus Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gratus Capital LLC holds 369,718 shares of PFE stock, worth $9.75 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

369,718

Previous 343,184 7.73%

Holding current value

$9.75 Million

Previous $9.52 Million 8.62%

% of portfolio

0.43%

Previous 0.45%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$25.26 - $29.6 $670,248 - $785,406	26,534 Added 7.73%	369,718 $10.3 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $260,349 - $298,964	10,056 Added 3.02%	343,184 $9.52 Million
Q4 2023 Feb 07, 2024	SELL	$26.13 - $33.94 $218,708 - $284,077	-8,370 Reduced 2.45%	333,128 $9.59 Million
Q3 2023 Oct 26, 2023	BUY	$32.09 - $37.51 $174,537 - $204,016	5,439 Added 1.62%	341,498 $11.3 Million
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $453,233 - $524,380	12,548 Added 3.88%	336,059 $12.3 Million
Q1 2023 Apr 19, 2023	SELL	$39.39 - $51.28 $51,837 - $67,484	-1,316 Reduced 0.41%	323,511 $13.2 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $659,232 - $860,555	15,790 Added 5.11%	324,827 $0
Q3 2022 Nov 03, 2022	BUY	$43.76 - $53.42 $1.13 Million - $1.38 Million	25,854 Added 9.13%	309,037 $13.5 Million
Q2 2022 Jul 29, 2022	BUY	$46.53 - $55.17 $505,176 - $598,980	10,857 Added 3.99%	283,183 $14.8 Million
Q1 2022 Apr 29, 2022	BUY	$45.75 - $56.69 $538,935 - $667,808	11,780 Added 4.52%	272,326 $14.1 Million
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $341,385 - $506,047	8,262 Added 3.27%	260,546 $15.4 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $699,906 - $899,089	17,832 Added 7.61%	252,284 $10.9 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $707,319 - $801,273	19,697 Added 9.17%	234,452 $9.18 Million
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $233,157 - $262,954	6,962 Added 3.35%	214,755 $7.78 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $280,244 - $356,354	8,373 Added 4.2%	207,793 $7.65 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $321,976 - $377,752	10,141 Added 5.36%	199,420 $7.32 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $19,096 - $23,166	-634 Reduced 0.33%	189,279 $6.19 Million
Q1 2020 May 01, 2020	BUY	$27.03 - $38.62 $4.35 Million - $6.22 Million	160,987 Added 556.55%	189,913 $6.2 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $131 - $149	4 Added 0.01%	28,926 $1.13 Million
Q3 2019 Oct 30, 2019	SELL	$32.49 - $42.13 $4.5 Million - $5.84 Million	-138,526 Reduced 82.73%	28,922 $1.04 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $82,058 - $92,132	2,219 Added 1.34%	167,448 $7.25 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $1.47 Million - $1.62 Million	-39,318 Reduced 19.22%	165,229 $7.02 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $294,834 - $336,143	-7,664 Reduced 3.61%	204,547 $8.93 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $448,983 - $511,890	11,671 Added 5.82%	212,211 $9.26 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $148,910 - $180,619	4,320 Added 2.2%	200,540 $8.84 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $37,795 - $40,293	-1,146 Reduced 0.58%	196,220 $7.12 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $648,730 - $752,616	-20,330 Reduced 9.34%	197,366 $7.01 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $5.75 Million - $6.1 Million	172,931 Added 386.31%	217,696 $7.89 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $806 - $887	26 Added 0.06%	44,765 $1.6 Million
Q2 2017 Aug 08, 2017	BUY	N/A	44,739	44,739 $1.5 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Account

Gratus Capital LLC Pfizer Inc Transaction History